AmunBio Analysis
What is AmunBio?
Next-gen oncolytic virus therapy for cancer
HQ Country
Seattle, United States
Employees
1-10
Founded
2020
HQ State/Province
Washington
Funding Category
Seed
HQ Full Address
Seattle, Washington, United States
Product Features & Capabilities
- Engineered immunotherapeutic oncolytic viruses for cancer and hematological malignancies
Other Considerations
Early stage biotechnology company; Founded in 2020; HQ in Seattle, WA; Focus on engineered oncolytic virus platform
